Use cases Ambient AI Scribes for Clinical Documentation
Use case · Moderate risk tier

Ambient AI Scribes for Clinical Documentation

How ambient AI scribes reduce documentation time, after-hours charting, and clinician burnout in ambulatory care settings.

Health system · Medical group

What this is

Ambient AI scribes use large language models to convert patient-clinician conversations into structured clinical notes inside the EHR. The clinician speaks naturally during the visit; the tool listens, drafts, and presents a note for review and signature.

What the evidence shows

A prospective quality-improvement study at the University of Pennsylvania (Duggan et al., JAMA Network Open, February 2025) enrolled 46 clinicians across 17 medical specialties. The study found that ambient AI scribe use was associated with 20.4% less time in notes per appointment, 30.0% less after-hours work time per workday, and 9.3% higher same-day appointment closure rates.

A parallel study at Stanford Health Care (Shah et al., JAMIA, February 2025) of 48 physicians over three months found statistically significant reductions in task load (−24.42 points, p < .001) and burnout (−1.94 points, p < .001), with moderate improvements in usability scores (+10.9, p < .001).

A multicenter study across six US health systems (Olson et al., JAMA Network Open, October 2025) of 263 ambulatory clinicians found that after 30 days with an ambient AI scribe, the proportion experiencing burnout decreased from 51.9% to 38.8% (OR 0.26, 95% CI 0.13–0.54), with a mean reduction of 2.64 points on a 10-point cognitive task-load scale.

What changes operationally

The documentation workflow shifts from clinician-authored to clinician-reviewed. This requires new quality assurance processes: spot audits of AI-drafted notes, monitoring of note accuracy over time, and clear policies on what constitutes adequate review before signature.

Organizations should expect a 4–8 week adoption curve with significant inter-clinician variability. The Stanford pilot found utilization ranged widely across individual physicians.

Where this sits in the RUAIH framework

Classified as moderate risk. The tool generates clinical documentation that becomes part of the medical record, but a licensed clinician reviews and signs every note. The AI does not make clinical decisions, order treatments, or communicate directly with patients.

The operational record

Accountable ownerChief Medical Information Officer (CMIO) or ambulatory medical director, with ongoing input from the documentation quality and compliance teams
Baseline to measure firstTime in notes per appointment, after-hours EHR documentation time, same-day note closure rate, and clinician-reported cognitive task load and burnout scores
Reported effect size In a prospective quality-improvement study of 46 clinicians across 17 specialties at the University of Pennsylvania, Duggan et al. (2025) found ambient AI scribes were associated with 20.4% less time in notes per appointment (10.3 to 8.2 minutes, p < .001), 30.0% less after-hours work time (50.6 to 35.4 minutes per workday, p = .02), and 9.3% greater same-day appointment closure (66.2% to 72.4%, p < .001), published in JAMA Network Open on 3 February 2025
What changes in the workflowBefore: the clinician types or dictates notes during or after the visit, splitting attention between the patient and the screen. After: the ambient tool records the patient-clinician conversation, generates a draft clinical note, and presents it for review inside the EHR. The clinician reviews, edits, and signs the note. Dictation and after-hours pajama-time charting are substantially reduced, but the review-and-sign step remains a clinical responsibility that cannot be skipped.
Risk tier for governanceModerate risk tier

How it fails

Three failure modes, written before deployment rather than discovered after it. Each one belongs in the monitoring plan for this tool.

  1. The generated note omits or misrepresents a clinically relevant detail from the conversation — particularly medication dosages, laterality, or negated findings — and the clinician signs without catching the error because review fatigue sets in after weeks of high-accuracy drafts.
  2. The tool performs poorly in noisy clinical environments (emergency departments, urgent care with concurrent conversations, interpreter-mediated visits) because the underlying speech model cannot reliably separate speakers or handle code-switching between languages.
  3. Clinicians who use the tool for every visit lose the documentation-as-reasoning habit: the act of composing a note forces synthesis of the clinical picture, and outsourcing that act may degrade diagnostic thinking over time — a latent failure mode that would not appear in efficiency metrics.

When not to do this

Do not deploy ambient scribes where the clinical conversation itself is non-standard — interpreter-heavy clinics without validated multilingual models, behavioral health visits where documentation norms differ substantially from medical visits, or settings where patients have not been informed the conversation is being recorded and may not consent. Also inappropriate where note templates already enforce structured data entry that the ambient model would bypass, degrading downstream data quality for registries and quality reporting.

Governing this in production? The evidence library lists the artifacts an assessor asks for, the Mock Surveyor tests whether you could produce them on demand, and MGR is the open format for the record itself. This page describes an operational pattern and its published evidence. It is not clinical, safety or regulatory advice, and it is not a recommendation of any product.

Published under the Healthcare AI Institute editorial standard.

Written and reviewed against the standard by a physician-executive whose career spans three national healthcare systems. Last reviewed on 2026-08-17.

Researched from peer-reviewed studies in JAMA Network Open and JAMIA, then structured against the seven-field use-case framework. Every quantitative claim links to its source.

The Institute accepts no vendor sponsorship, holds no vendor equity and takes no referral fees.